FIELD: biotechnology.
SUBSTANCE: invention relates to biotechnology. described are methods of purifying the recombinant lentiviral vector (rLV).
EFFECT: invention enables to obtain highly purified rLV vector compositions on a scale required to satisfy requirements for human gene therapy.
38 cl, 9 dwg, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| RECOMBINANT LENTIVIRAL VECTOR, HOST CELL TRANSDUCED WITH LENTIVIRAL VECTOR, METHODS FOR TRANSDUCTION AND USES THEREOF | 2002 |
|
RU2305708C2 |
| COMPLETELY SCALABLE METHOD FOR PRODUCING rAAV BASED ON COLUMNS | 2017 |
|
RU2754467C2 |
| SCALABLE METHODS FOR OBTAINING RECOMBINANT VECTOR BASED ON ADENO-ASSOCIATED VIRUS (AAV) IN SYSTEM OF SERUM-FREE SUSPENSION CELL CULTURE, SUITABLE FOR CLINICAL USE | 2016 |
|
RU2766583C2 |
| AMPLIFIER AGENTS TO INCREASE CELL TRANSFECTION AND/OR rAAV VECTOR PRODUCTION | 2018 |
|
RU2802520C2 |
| STABLE CELL LINES FOR RETROVIRUSES PRODUCTION | 2016 |
|
RU2752498C2 |
| GENETIC CONSTRUCTS AND THEIR MIXTURES FOR ANTI-HIV THERAPY | 2017 |
|
RU2666991C1 |
| METHOD FOR TEMPORARY TRANSFECTION FOR PRODUCING RETROVIRUS | 2016 |
|
RU2749717C2 |
| METHODS OF OBTAINMENT AND APPLICATION OF MULTIPOTENT CELL POPULATIONS | 2008 |
|
RU2535365C2 |
| BUFFERS FOR STABILIZING LENTIVIRAL DRUGS | 2016 |
|
RU2747231C2 |
| VIRAL VECTORS CLEANING SYSTEM | 2012 |
|
RU2607044C2 |
